Cryo-Cell International, Inc.
CCEL
$3.10
$0.165.44%
AMEX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -704.15% | 94.70% | 98.16% | 101.32% | 104.22% |
| Total Depreciation and Amortization | 33.92% | 26.11% | 14.97% | -15.60% | -40.27% |
| Total Amortization of Deferred Charges | -1.89% | -1.88% | -1.87% | -1.86% | -1.85% |
| Total Other Non-Cash Items | 325.60% | -80.79% | -87.44% | -89.73% | -91.94% |
| Change in Net Operating Assets | -23.31% | -26.91% | -12.75% | 9.12% | -38.16% |
| Cash from Operations | -8.86% | -11.72% | -6.68% | 5.82% | -32.61% |
| Capital Expenditure | 90.41% | 95.83% | 95.59% | 70.99% | 64.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.24% | -6.87% | -169.87% | -675.99% | -89.40% |
| Cash from Investing | 80.00% | 68.63% | 57.80% | 33.78% | 40.12% |
| Total Debt Issued | 68.58% | 175.63% | 112.53% | 272.11% | 449.47% |
| Total Debt Repaid | -232.36% | -107.50% | -252.87% | -146.45% | -41.87% |
| Issuance of Common Stock | -69.76% | 9,750.00% | -- | -- | -- |
| Repurchase of Common Stock | 88.10% | 88.10% | 92.58% | -72.59% | -78.19% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -59.92% | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -100.00% | 437.78% | 437.78% |
| Cash from Financing | -384.64% | -143.52% | -372.80% | -231.47% | 52.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -256.27% | 117.54% | 49.34% | 97.87% | 111.93% |